VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
3213
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
579
Interactions with Platform & by Email
PARTICIPANTS
96
Unique # Participated
VALIDATIONS
43
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
142
PAGES
218
EDITION
9
PRICE
USD $5450
Is the U.S. Still a Better Global Barometer than China?
Amid the COVID-19 crisis, the global market for NGS-based RNA-seq estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$5.3 Billion by 2027, growing at a CAGR of 19.9% over the analysis period 2020-2027. Sample Preparation, one of the segments analyzed in the report, is projected to record a 16% CAGR and reach US$998.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sequencing Platforms & Consumables for RNA-Seq segment is readjusted to a revised 22.8% CAGR for the next 7-year period.
The NGS-based RNA-seq market in the U.S. is estimated at US$438 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$918.6 Million by the year 2027 trailing a CAGR of 19.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.8% and 17.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.8% CAGR.
In the global RNA Sequencing Services segment, USA, Canada, Japan, China and Europe will drive the 20% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$284 Million in the year 2020 will reach a projected size of US$1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$654.6 Million by the year 2027.We bring years of research experience to this 9th edition of our report. The 218-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Agilent Technologies, Inc.; Eurofins Scientific; F. Hoffmann-La Roche AG; GATC Biotech AG; Illumina, Inc.; Macrogen, Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California, Inc.; PerkinElmer, Inc.; Qiagen NV; Thermo Fisher Scientific, Inc.
» Application (De Novo Transcriptome Assembly, Expression Profiling Analysis, Variant Calling and Transcriptome Epigenetics, Small RNA Sequencing) » End-Use (Research Centers & Academic & Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Other End-Uses) » Products & Services (Sample Preparation, Sequencing Platforms & Consumables for RNA-Seq, RNA Sequencing Services, Data Analysis, Storage, and Management) » Technology (Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-molecule Real-time (SMRT) Sequencing, Nanopore Sequencing)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| RNA-Seq: An Introduction |
| A Prelude to NGS-based RNA-seq Market |
| North America: The Largest Market for NGS-based RNA-seq |
| Global Competitor Market Shares |
| NGS-based RNA-seq Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| NGS-based RNA-seq Market Drivers and Restraints |
| Recent Advances in RNA Sequence Analysis |
| Select Players of NGS-based RNA-seq Market |
| Rise in Research Grants to Improve Activities in NGS-based RNA-Sequencing Technique |
| Application of RNA-Seq in Precision Medicine |
| Next Generation Sequencing in Cancer Research |
| Next Generation Sequencing for Transcriptomic Profiling |
| 4. GLOBAL MARKET PERSPECTIVE |
| NGS-based RNA-seq Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| NGS-based RNA-seq Market Share Shift across Key Geographies Worldwide: 2020 VS 2027 |
| Sample Preparation (Products & Services) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Sample Preparation (Products & Services) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| Sequencing Platforms & Consumables for RNA-Seq (Products & Services) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027 |
| Sequencing Platforms & Consumables for RNA-Seq (Products & Services) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027 |
| RNA Sequencing Services (Products & Services) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027 |
| RNA Sequencing Services (Products & Services) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Data Analysis, Storage, and Management (Products & Services) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027 |
| Data Analysis, Storage, and Management (Products & Services) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Sequencing by Synthesis (SBS) (Technology) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Sequencing by Synthesis (SBS) (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Ion Semiconductor Sequencing (Technology) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020 to 2027 |
| Ion Semiconductor Sequencing (Technology) Market Percentage Share Distribution by Region/Country: 2020 VS 2027 |
| Single-molecule Real-time (SMRT) Sequencing (Technology) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2020 to 2027 |
| Single-molecule Real-time (SMRT) Sequencing (Technology) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027 |
| Nanopore Sequencing (Technology) World Market by Region/Country in US$ Thousand: 2020 to 2027 |
| Nanopore Sequencing (Technology) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027 |
| De Novo Transcriptome Assembly (Application) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| De Novo Transcriptome Assembly (Application) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Expression Profiling Analysis (Application) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 |
| Expression Profiling Analysis (Application) Share Breakdown Review by Region/Country: 2020 VS 2027 |
| Variant Calling and Transcriptome Epigenetics (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Variant Calling and Transcriptome Epigenetics (Application) Distribution of Global Sales by Region/Country: 2020 VS 2027 |
| Small RNA Sequencing (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027 |
| Small RNA Sequencing (Application) Global Market Share Distribution by Region/Country for 2020 and 2027 |
| Research Centers & Academic & Government Institutes (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027 |
| Research Centers & Academic & Government Institutes (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2020 VS 2027 |
| Hospitals & Clinics (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027 |
| Hospitals & Clinics (End-Use) Market Share Shift across Key Geographies: 2020 VS 2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027 |
| Pharmaceutical & Biotechnology Companies (End-Use) Market Share Breakdown by Region/Country: 2020 VS 2027 |
| Other End-Uses (End-Use) Demand Potential Worldwide in US$ Thousand by Region/Country: 2020-2027 |
| Other End-Uses (End-Use) Share Breakdown Review by Region/Country: 2020 VS 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US NGS-based RNA-seq Market Share (in %) by Company: 2019 & 2025 |
| United States NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Products & Services: 2020 to 2027 |
| United States NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027 |
| NGS-based RNA-seq Market in US$ Thousand in the United States by Technology: 2020-2027 |
| United States NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027 |
| United States NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by Application: 2020 to 2027 |
| NGS-based RNA-seq Market Share Breakdown in the United States by Application: 2020 VS 2027 |
| United States NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027 |
| NGS-based RNA-seq Market Share Breakdown in the United States by End-Use: 2020 VS 2027 |
| CANADA |
| Canadian NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020 to 2027 |
| NGS-based RNA-seq Market in Canada: Percentage Share Breakdown of Sales by Products & Services for 2020 and 2027 |
| NGS-based RNA-seq Market Analysis in Canada in US$ Thousand by Technology: 2020-2027 |
| Canadian NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027 |
| Canadian NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 |
| Canadian NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027 |
| Canadian NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Canadian NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027 |
| JAPAN |
| Japanese Market for NGS-based RNA-seq: Annual Sales Estimates and Projections in US$ Thousand by Products & Services for the Period 2020-2027 |
| Japanese NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027 |
| Japanese Medium & Long-Term Outlook for NGS-based RNA-seq Market in US$ Thousand by Technology: 2020-2027 |
| Japanese NGS-based RNA-seq Market Percentage Share Distribution by Technology: 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027 |
| NGS-based RNA-seq Market Share Shift in Japan by Application: 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027 |
| NGS-based RNA-seq Market Share Shift in Japan by End-Use: 2020 VS 2027 |
| CHINA |
| Chinese NGS-based RNA-seq Market Growth Prospects in US$ Thousand by Products & Services for the Period 2020-2027 |
| Chinese NGS-based RNA-seq Market by Products & Services: Percentage Breakdown of Sales for 2020 and 2027 |
| NGS-based RNA-seq Market Estimates and Forecasts in China in US$ Thousand by Technology: 2020-2027 |
| NGS-based RNA-seq Market in China: Percentage Share Analysis by Technology for 2020 and 2027 |
| Chinese Demand for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027 |
| Chinese NGS-based RNA-seq Market Share Breakdown by Application: 2020 VS 2027 |
| Chinese Demand for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027 |
| Chinese NGS-based RNA-seq Market Share Breakdown by End-Use: 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European NGS-based RNA-seq Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European NGS-based RNA-seq Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| European NGS-based RNA-seq Market Share Shift by Region/Country: 2020 VS 2027 |
| European NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020-2027 |
| European NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027 |
| European NGS-based RNA-seq Market Assessment in US$ Thousand by Technology: 2020-2027 |
| NGS-based RNA-seq Market in Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 |
| European NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 |
| European NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027 |
| European NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| European NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027 |
| FRANCE |
| NGS-based RNA-seq Market in France by Products & Services: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| French NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027 |
| French NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Technology: 2020-2027 |
| French NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027 |
| NGS-based RNA-seq Quantitative Demand Analysis in France in US$ Thousand by Application: 2020-2027 |
| French NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027 |
| NGS-based RNA-seq Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027 |
| French NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| GERMANY |
| NGS-based RNA-seq Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Products & Services for the Period 2020-2027 |
| German NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027 |
| German NGS-based RNA-seq Latent Demand Forecasts in US$ Thousand by Technology: 2020-2027 |
| German NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027 |
| NGS-based RNA-seq Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2020-2027 |
| NGS-based RNA-seq Market Share Distribution in Germany by Application: 2020 VS 2027 |
| NGS-based RNA-seq Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027 |
| NGS-based RNA-seq Market Share Distribution in Germany by End-Use: 2020 VS 2027 |
| ITALY |
| Italian NGS-based RNA-seq Market Growth Prospects in US$ Thousand by Products & Services for the Period 2020-2027 |
| Italian NGS-based RNA-seq Market by Products & Services: Percentage Breakdown of Sales for 2020 and 2027 |
| NGS-based RNA-seq Market Estimates and Forecasts in Italy in US$ Thousand by Technology: 2020-2027 |
| NGS-based RNA-seq Market in Italy: Percentage Share Analysis by Technology for 2020 and 2027 |
| Italian Demand for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027 |
| Italian NGS-based RNA-seq Market Share Breakdown by Application: 2020 VS 2027 |
| Italian Demand for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027 |
| Italian NGS-based RNA-seq Market Share Breakdown by End-Use: 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for NGS-based RNA-seq: Annual Sales Estimates and Projections in US$ Thousand by Products & Services for the Period 2020-2027 |
| United Kingdom NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027 |
| United Kingdom Medium & Long-Term Outlook for NGS-based RNA-seq Market in US$ Thousand by Technology: 2020-2027 |
| United Kingdom NGS-based RNA-seq Market Percentage Share Distribution by Technology: 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by Application: 2020 to 2027 |
| NGS-based RNA-seq Market Share Shift in the United Kingdom by Application: 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for NGS-based RNA-seq in US$ Thousand by End-Use: 2020 to 2027 |
| NGS-based RNA-seq Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020-2027 |
| Rest of Europe NGS-based RNA-seq Market Share Breakdown by Products & Services: 2020 VS 2027 |
| Rest of Europe NGS-based RNA-seq Market Assessment in US$ Thousand by Technology: 2020-2027 |
| NGS-based RNA-seq Market in Rest of Europe: Percentage Breakdown of Sales by Technology for 2020 and 2027 |
| Rest of Europe NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by Application: 2020-2027 |
| Rest of Europe NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027 |
| Rest of Europe NGS-based RNA-seq Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027 |
| Rest of Europe NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027 |
| ASIA-PACIFIC |
| NGS-based RNA-seq Market in Asia-Pacific by Products & Services: Estimates and Projections in US$ Thousand for the Period 2020-2027 |
| Asia-Pacific NGS-based RNA-seq Market Share Analysis by Products & Services: 2020 VS 2027 |
| Asia-Pacific NGS-based RNA-seq Market Estimates and Projections in US$ Thousand by Technology: 2020-2027 |
| Asia-Pacific NGS-based RNA-seq Historic Market Analysis in US$ Thousand by Technology: 2020 VS 2027 |
| NGS-based RNA-seq Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2020-2027 |
| Asia-Pacific NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by Application for 2020 and 2027 |
| NGS-based RNA-seq Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027 |
| Asia-Pacific NGS-based RNA-seq Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027 |
| REST OF WORLD |
| Rest of World NGS-based RNA-seq Market Estimates and Forecasts in US$ Thousand by Products & Services: 2020 to 2027 |
| NGS-based RNA-seq Market in Rest of World: Percentage Share Breakdown of Sales by Products & Services for 2020 and 2027 |
| NGS-based RNA-seq Market Analysis in Rest of World in US$ Thousand by Technology: 2020-2027 |
| Rest of World NGS-based RNA-seq Market Share Breakdown by Technology: 2020 VS 2027 |
| Rest of World NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by Application: 2020 to 2027 |
| Rest of World NGS-based RNA-seq Market Share Analysis by Application: 2020 VS 2027 |
| Rest of World NGS-based RNA-seq Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027 |
| Rest of World NGS-based RNA-seq Market Share Analysis by End-Use: 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 46 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com